Cargando…

Risk factors for radiation-induced lung injury in patients with advanced non-small cell lung cancer: implication for treatment strategies

BACKGROUND: The radiation-induced lung injury (RILI) in patients with advanced non-small cell lung cancer (NSCLS) is very common in clinical settings; we aimed to evaluate the risk factors of RILI in NSCLS patients, to provide insights into the treatment of NSCLS. METHODS: NSCLC patients undergoing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sha, Sha, Dong, Jigang, Wang, Maoyu, Chen, Ziyu, Gao, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285849/ https://www.ncbi.nlm.nih.gov/pubmed/34271911 http://dx.doi.org/10.1186/s12957-021-02321-3

Ejemplares similares

Effect of antibiotic use on the efficacy of nivolumab in the treatment of advanced/metastatic non-small cell lung cancer: A meta-analysis
por: Huo, Geng-wei, et al.
Publicado: (2021)

Radiation therapy for patients with brain metastases from non-small cell lung cancer without driven gene mutation
por: Li, Pei-Jie, et al.
Publicado: (2020)

Advances in efficacy prediction and monitoring of neoadjuvant immunotherapy for non-small cell lung cancer
por: Wang, Yunzhen, et al.
Publicado: (2023)

The incidence of gastrointestinal adverse events in patients with advanced non-small cell lung cancer (NSCLC) treated with PD-1 inhibitors: a meta-analysis
por: Huo, Geng-Wei, et al.
Publicado: (2021)

Strategies targeting angiogenesis in advanced non-small cell lung cancer
por: Wang, Jun, et al.
Publicado: (2017)

Factors predicting radiation pneumonitis in locally advanced non-small cell lung cancer
por: Kim, Myungsoo, et al.
Publicado: (2011)

Exploring the implications of modified advanced lung cancer inflammation index on outcomes in patients with advanced non-small cell lung cancer
por: Mahajan, Abhishek, et al.
Publicado: (2023)

Application of Multigroup Technology in Non-Small-Cell Lung Cancer with Qi Stagnation and Blood Stasis Syndrome
por: Ma, Guan-Jun, et al.
Publicado: (2021)

Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer
por: Chen, Zhong-qing, et al.
Publicado: (2018)

To be, or not to be: the dilemma of immunotherapy for non-small cell lung cancer harboring various driver mutations
por: Cai, Ruoxue, et al.
Publicado: (2023)

Pembrolizumab in advanced non-small cell lung cancer: safety implications of dose adjustments
por: Gower, Arjan, et al.
Publicado: (2022)

Relationship between plasma circulating cell-free DNA concentration and treatment outcomes including prognosis in patients with advanced non-small cell lung cancer
por: Peng, Wei-Wei, et al.
Publicado: (2023)

High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis
por: Szejniuk, Weronika Maria, et al.
Publicado: (2021)

Current immune therapeutic strategies in advanced or metastatic non-small cell lung cancer
por: Xu, Jing, et al.
Publicado: (2023)

sLAG-3 in non-small-cell lung cancer patients’ serum
por: He, Yayi, et al.
Publicado: (2018)

Functional dosimetric metrics for predicting radiation-induced lung injury in non-small cell lung cancer patients treated with chemoradiotherapy
por: Wang, Dongqing, et al.
Publicado: (2012)

Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics?
por: Thomas, Hannah M. T., et al.
Publicado: (2022)

P16 (INK4a) gene promoter methylation as a biomarker for the diagnosis of non‐small cell lung cancer: An updated meta‐analysis
por: Tuo, Lei, et al.
Publicado: (2018)

Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer
por: Hassanzadeh, Comron, et al.
Publicado: (2020)

Nrf2 Mediates Metabolic Reprogramming in Non-Small Cell Lung Cancer
por: Zhao, Jiangang, et al.
Publicado: (2020)

Hypofractionation and Stereotactic Body Radiation Therapy in Inoperable Locally Advanced Non-small Cell Lung Cancer
por: Rico, Mikel, et al.
Publicado: (2021)

Landscape and clinical impact of metabolic alterations in non-squamous non-small cell lung cancer
por: Ivanina Foureau, Anna V., et al.
Publicado: (2022)

Clinical observation of Pemetrexed first-line treatment in advanced non-squamous lung cancer or non-small cell lung cancer without driver-mutations: a phase 2, single-arm trial
por: Sha, Zhou, et al.
Publicado: (2020)

The resistance mechanisms and treatment strategies for EGFR-mutant advanced non-small-cell lung cancer
por: Zhong, Wen-Zhao, et al.
Publicado: (2017)

State-of-the-art combination treatment strategies for advanced stage non–small cell lung cancer
por: Yao, Yongfang, et al.
Publicado: (2022)

Immunotherapy progress and clinical strategy of unresectable locally advanced non-small cell lung cancer
por: Zhang, Xiaofei, et al.
Publicado: (2023)

Effectiveness of Proanthocyanidin plus Trimetazidine in the Treatment of Non-Small-Cell Lung Cancer with Radiation Heart Injury
por: Yin, Hang, et al.
Publicado: (2022)

miR-122 inhibits metastasis and epithelial–mesenchymal transition of non-small-cell lung cancer cells
por: Qin, Haifeng, et al.
Publicado: (2015)

Analysis of the characteristics and prognosis of advanced non-small-cell lung cancer in older patients
por: Gao, Ying, et al.
Publicado: (2015)

Sinomenine Inhibits Non-Small Cell Lung Cancer via Downregulation of Hexokinases II-Mediated Aerobic Glycolysis
por: Liu, Wenbin, et al.
Publicado: (2020)

The CT appearance pattern of radiation-induced lung injury and tumor recurrence after stereotactic body radiation therapy in early stage non-small cell lung cancer
por: Li, Qian, et al.
Publicado: (2020)

Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer
por: Daniello, Lea, et al.
Publicado: (2021)

Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics
por: Padinharayil, Hafiza, et al.
Publicado: (2022)

Efficacy and safety of nintedanib in patients with non-small cell lung cancer, and novel insights in radiation-induced lung toxicity
por: Yan, Shu, et al.
Publicado: (2023)

Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer
por: Sirhan, Zaid, et al.
Publicado: (2023)

Has the practice of radiation oncology for locally advanced and metastatic non-small-cell lung cancer changed in Canada?
por: Han, K., et al.
Publicado: (2010)

Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer
por: Karam, Sana D, et al.
Publicado: (2013)

The use of dose-escalated radiation for locally advanced non-small cell lung cancer in the U.S., 2004–2013
por: Christodouleas, John P., et al.
Publicado: (2017)

Locally Advanced Non Small Cell Lung Cancer: The Case for Radiation Dose De-escalation in the Management of the Mediastinum
por: Soyfer, Viacheslav, et al.
Publicado: (2019)

Pneumonitis in advanced non-small cell lung cancer: no interaction between immune checkpoint inhibition and radiation therapy
por: Neibart, Shane S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m0sc70te9dda8htu8v0mc1gnn6